Literature DB >> 21041615

Atherosclerosis and incident depression in late life.

Rachel S Newson1, Karin Hek, Hendrika J Luijendijk, Albert Hofman, Jacqueline C M Witteman, Henning Tiemeier.   

Abstract

CONTEXT: Depression is a prominent concern for older adults; therefore, it is important to identify causal mechanisms so that prevention and treatment strategies can be developed. The vascular depression hypothesis proposes that vascular factors precede the onset of depression in older adults. However, although cross-sectional associations have been established, owing to a lack of objective assessments and longitudinal data, the validity and temporal nature of this relationship is unclear.
OBJECTIVE: To examine whether atherosclerosis, an asymptomatic subclinical indicator of vascular burden, increases the risk of developing depression in older adults.
DESIGN: Prospective, population-based study.
SETTING: Set within the Rotterdam study, participants were assessed on objective measures of generalized atherosclerosis at baseline (1997-1999) and followed up for an average of 6 years for incident depression. PARTICIPANTS: The baseline sample consisted of 3564 participants (56% female) with a mean age of 72 years who initially did not have depression or dementia. MAIN OUTCOME MEASURES: Depression was categorized into symptoms or syndromes and assessed in a multidimensional manner from physician and mental health specialist reports, pharmacy records (antidepressant usage), a clinical interview, and self-report.
RESULTS: During 21 083 person-years, 429 incidents of depressive symptoms and 197 incidents of depressive syndromes occurred. Individual atherosclerotic measures and a composite measure were not predictive of incident depressive symptoms (composite measure hazard ratio, 0.93; 95% confidence interval, 0.83-1.05) or incident depressive syndromes (composite measure hazard ratio, 0.97; 95% confidence interval, 0.81-1.16). An a priori power analysis indicated a sufficient sample size (α = .05; 0.95 power).
CONCLUSIONS: Atherosclerosis does not appear to increase the risk of incident depression in older adults. These findings do not support the vascular depression hypothesis and, alternatively, taking findings from prior studies into account, suggest either that depression contributes to vascular burden or that both result from an underlying biological substrate.

Entities:  

Mesh:

Year:  2010        PMID: 21041615     DOI: 10.1001/archgenpsychiatry.2010.142

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  13 in total

1.  Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study.

Authors:  Wayne Katon; Courtney R Lyles; Melissa M Parker; Andrew J Karter; Elbert S Huang; Rachel A Whitmer
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

2.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

3.  The Rotterdam Study: 2014 objectives and design update.

Authors:  Albert Hofman; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2013-11-21       Impact factor: 8.082

4.  Organic bases of late-life depression: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2013-01-25       Impact factor: 3.575

5.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

6.  Role of Late-Life Depression in the Association of Subclinical Cardiovascular Disease With All-Cause Mortality: Cardiovascular Health Study.

Authors:  Nicole M Armstrong; Michelle C Carlson; Qian-Li Xue; Jennifer Schrack; Mercedes R Carnethon; Paulo H M Chaves; Alden L Gross
Journal:  J Aging Health       Date:  2017-11-28

7.  Epidemiology and Management of Depression Following Coronary Heart Disease Diagnosis in Women.

Authors:  Siqin Ye; Ellen-Ge Denton; Lauren T Wasson; Karina W Davidson
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-02-22

8.  Vascular risk status as a predictor of later-life depressive symptoms: a cohort study.

Authors:  Mika Kivimäki; Martin J Shipley; Charlotte L Allan; Claire E Sexton; Markus Jokela; Marianna Virtanen; Henning Tiemeier; Klaus P Ebmeier; Archana Singh-Manoux
Journal:  Biol Psychiatry       Date:  2012-03-17       Impact factor: 13.382

9.  The MentDis_ICF65+ study protocol: prevalence, 1-year incidence and symptom severity of mental disorders in the elderly and their relationship to impairment, functioning (ICF) and service utilisation.

Authors:  Sylke Andreas; Martin Härter; Jana Volkert; Maria Hausberg; Susanne Sehner; Karl Wegscheider; Sven Rabung; Berta Ausín; Alessandra Canuto; Chiara Da Ronch; Luigi Grassi; Yael Hershkovitz; Paul Lelliott; Manuel Muñoz; Alan Quirk; Ora Rotenstein; Ana Belén Santos-Olmo; Arieh Shalev; Jens Siegert; Kerstin Weber; Hans-Ulrich Wittchen; Uwe Koch; Holger Schulz
Journal:  BMC Psychiatry       Date:  2013-02-18       Impact factor: 3.630

10.  Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study.

Authors:  Yael D Reijmer; Manon Brundel; Jeroen de Bresser; L Jaap Kappelle; Alexander Leemans; Geert Jan Biessels
Journal:  Diabetes Care       Date:  2012-09-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.